Austin Yang

3 weeks ago | jamanetwork.com | Omar Elghawy |Jonathan Sussman |Austin Yang |Colin Thomas

Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma (CTCL). Recent clinical trials have investigated immune checkpoint inhibitors (ICIs) as monotherapy or combination therapies for MF/SS with mixed results.1-3 Clinical data for ICIs in CTCL are sparse, limited primarily to case reports or small case series.